Wikidata

(Q39678301)

English

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

scientific article published on 19 July 2010

In more languages

Statements

title
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
author name string
Soken-Nakazawa J Song
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
Naohisa Tomosugi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
Hiroshi Kawabata
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
Takayuki Ishikawa
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
Teppei Nishikawa
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
Kazuyuki Yoshizaki
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
publication date
19 July 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017
page(s)
3627-3634
1 reference
stated in
Europe PubMed Central
PubMed ID
20644113
retrieved
13 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39678301&oldid=1854659030"